By jwhitleContemporary process analytical technologies (PATs) for biomanufacturing are available for continuously monitoring a small set of analytical targets or are limited by costly and time-consuming offline efforts. With the prime focus of the biopharmaceutical industry crystallizing around monoclonal antibodies and cell/gene therapies and the need for nimble, efficient production platforms, it is more relevant than ever to create scalable, in-line, and high throughput quantification methods. Learn about the AIM-Bio research that is underway at NC State in the lab of Dr. Michael Daniele, associate professor in the Department of Electrical and Computer Engineering. |2023 Q2
By jwhitleDTU and NC State delivered four AIM-Bio lifelong learning courses in March and April 2023. The 48 participants enrolled included 28 working professionals and 20 graduate students. The four courses — Biopharmaceutical Lyophilization and Spray Drying, Upstream Process Development for Biopharmaceutical Production, Biomanufacturing Operations and cGMP, and Automation and Control of Yeast Fermentation —included both significant hands-on laboratory experiences and classroom instruction. Read the full article to learn about the courses and attendees’ countries of origin. |2023 Q1
By jwhitleThe Novo Nordisk Foundation recently funded a grant — Real-time sustainability analysis for Industry 4.0 (Sustain 4.0) — that will enhance the collaboration between NC... |2023 Q1
By jwhitleThe AIM-Bio collaboration between NC State and DTU began in January 2020 with $27 million in funding provided by the Novo Nordisk Foundation. The program... |2023 Q1
By jwhitleEurope’s biotech industry is experiencing an expansion phase that has led to an increasing need for additional employees in Medicon Valley, a top life science... |2022 Q4
By jwhitleThe AIM-Bio Biopharmaceutical Manufacturing Symposium held Nov. 9–11, 2022, provided an excellent opportunity for members of the AIM-Bio project team to begin brainstorming the future... |2022 Q4
By jwhitleThe third annual Accelerated Innovation in Manufacturing Biologics (AIM-Bio) Symposium, which took place Nov. 9–11, 2022, was the first symposium to be held in person.... |2022 Q4
By jwhitleThe third annual AIM-Bio Biopharmaceutical Manufacturing Symposium, which was held at NC State University Nov. 9–11, 2022, was attended by over 80 people. Participating were... |2022 Q3
By jwhitleStefano Menegatti, professor in the Department of Chemical and Biomolecular Engineering at NC State University, specializes in technological innovation in downstream bioprocessing and analytics. He... |2022 Q3
By jwhitleAfter collaborating across two continents since 2020, when the AIM-Bio program began, colleagues from North Carolina State University and the Technical University of Denmark (DTU) will gather in person at NC State Nov. 9–11, 2022, for the program’s annual symposium. The three-day meeting will feature several keynote speakers, presentations and poster sessions, tours of laboratories, and additional activities.